Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
AUROBINDO PHARMA LTD.
Aurobindo Pharma Ltd.
NSE: AUROPHARMA | BSE: 524804
Turnaround Potential
In 3 Starfolio Baskets
1220.40
-0.30
(
-0.02
%)
Near 52W High of ₹1278.60
1.8M
NSE+BSE Volume
NSE
27 Feb, 2026 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
US FDA Approval
Aurobindo Pharma's arm gets US FDA nod to market Everolimus tablets, with a market size of $78 mn
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Detailed Stock Analysis for Aurobindo Pharma with Real-time Stock Report
Download Sample Report
Premium Feature
Please subscribe to GuruQ or StratQ
Subscribe
Sign in